Abstract
Since the publication of the first textbook on autoimmune diseases in 1963, the knowledge in the field has exponentially grown into numerous tracks of research, particularly at benchside. Systemic and organ-specific autoimmune diseases, as in the case of the liver, have witnessed notable advances in terms of epidemiology, genetics, effector and regulatory mechanisms, and ultimately treatment. While the available tools for communication have provided accelerating progress rates, we recognize that key opinion leaders continue to provide significant contributions to the field. The present issue is dedicated to celebrate Giorgina Mieli-Vergani and Diego Vergani as two of the finest examples of excellence in autoimmune liver diseases and the broader field of autoimmunity. Diego and Giorgina are extremely well-liked Colleagues who fully represent the translational efforts between laboratory research and clinically relevant questions in the practice of pediatric liver diseases and autoimmune hepatitis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-6 |
| Number of pages | 6 |
| Journal | Journal of Autoimmunity |
| Volume | 66 |
| DOIs | |
| State | Published - Jan 1 2016 |
Fingerprint
Keywords
- Antinuclear antibody
- Autoantibody
- Autoimmune liver disease
- Effector and regulatory T cells
- Liver immunology
- Lymphoid liver
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
Cite this
Diego and Giorgina Vergani : The two hearts of translational autoimmunity. / Liberal, Rodrigo; Selmi, Carlo; Gershwin, M. Eric.
In: Journal of Autoimmunity, Vol. 66, 01.01.2016, p. 1-6.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Diego and Giorgina Vergani
T2 - The two hearts of translational autoimmunity
AU - Liberal, Rodrigo
AU - Selmi, Carlo
AU - Gershwin, M. Eric
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Since the publication of the first textbook on autoimmune diseases in 1963, the knowledge in the field has exponentially grown into numerous tracks of research, particularly at benchside. Systemic and organ-specific autoimmune diseases, as in the case of the liver, have witnessed notable advances in terms of epidemiology, genetics, effector and regulatory mechanisms, and ultimately treatment. While the available tools for communication have provided accelerating progress rates, we recognize that key opinion leaders continue to provide significant contributions to the field. The present issue is dedicated to celebrate Giorgina Mieli-Vergani and Diego Vergani as two of the finest examples of excellence in autoimmune liver diseases and the broader field of autoimmunity. Diego and Giorgina are extremely well-liked Colleagues who fully represent the translational efforts between laboratory research and clinically relevant questions in the practice of pediatric liver diseases and autoimmune hepatitis.
AB - Since the publication of the first textbook on autoimmune diseases in 1963, the knowledge in the field has exponentially grown into numerous tracks of research, particularly at benchside. Systemic and organ-specific autoimmune diseases, as in the case of the liver, have witnessed notable advances in terms of epidemiology, genetics, effector and regulatory mechanisms, and ultimately treatment. While the available tools for communication have provided accelerating progress rates, we recognize that key opinion leaders continue to provide significant contributions to the field. The present issue is dedicated to celebrate Giorgina Mieli-Vergani and Diego Vergani as two of the finest examples of excellence in autoimmune liver diseases and the broader field of autoimmunity. Diego and Giorgina are extremely well-liked Colleagues who fully represent the translational efforts between laboratory research and clinically relevant questions in the practice of pediatric liver diseases and autoimmune hepatitis.
KW - Antinuclear antibody
KW - Autoantibody
KW - Autoimmune liver disease
KW - Effector and regulatory T cells
KW - Liver immunology
KW - Lymphoid liver
UR - http://www.scopus.com/inward/record.url?scp=84953288431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84953288431&partnerID=8YFLogxK
U2 - 10.1016/j.jaut.2015.11.004
DO - 10.1016/j.jaut.2015.11.004
M3 - Article
C2 - 26746139
AN - SCOPUS:84953288431
VL - 66
SP - 1
EP - 6
JO - Journal of Autoimmunity
JF - Journal of Autoimmunity
SN - 0896-8411
ER -